incretin and glp-1 Representation of the effect mediated by GIP under Incretin hormones and the satiation

Victoza (liraglutide) product information

A substudy of SURPASS-3 investigated glycemia using continuous glucose monitoring (CGM) (73)

CoverWell: A Safety Net for Patients and Providers in Peptide/GLP-1 and Regenerative Therapies Modern regenerative medicinecovering GLP-1s, peptides, stem cells, and exosomes offers life-changing possibilities in weight loss, longevity, recovery, and performance optimization

Q3: How much weight loss does retatrutide produce in trials

It induces lipolysis (fat breakdown) in adipose tissue, increasing the production of free fatty acids and ketone bodies

Across the 40 weeks of treatment, weight loss ranged from 6.2 to 8.8 kg (greater than what was seen in early Phase 2 semaglutide trials) (NCT03954834)